Psychiatry and Neurology, Neurology · Texarkana, TX
NPI
1407880305
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1002 Texas Blvd, Ste 401
Texarkana, TX, 75501
Phone (903) 794-6544
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
208 services
Medicare patients, 2024
97
Average age 75
Drug cost, 2024
$305K
123 prescriptions
Company payments, 2025
$1,303
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khalid Malik was code 99223 (hospital e&m - initial), 87 times for 79 patients. In total Khalid Malik billed 208 services in 12 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99223 Hospital E&M - Initial | Facility | 87 | 79 | $110.61 | $9,623 |
| 99233 Hospital E&M - Subsequent | Facility | 76 | 37 | $80.23 | $6,097 |
| 95816 Neurologic | Facility | 23 | 23 | $36.86 | $848 |
By year: 2022 $41K for 414 services; 2023 $34K for 349 services; 2024 $19K for 208 services.
Medicare prescription drug claims, 2024
In 2024, the drug Khalid Malik prescribed most often to Medicare patients was Xembify (Immune Globulin,gamma(Igg)klhw), with 24 prescriptions and refills. In total Khalid Malik wrote 123 Medicare prescriptions that cost $305K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xembify Immune Globulin,gamma(Igg)klhw | 24 | 24 | Under 11 | $303K |
Brand drugs: 28 claims; generic drugs: 95 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khalid Malik $1,303 ($1,303 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $310.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $310 |
| Lundbeck LLC | 11 | $236 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $219 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $89.17 |
| Eisai Inc. 4523.T | 3 | $88.28 |
| Genentech USA, Inc. ROG.SW | 3 | $82.19 |
| Axsome Therapeutics, Inc. AXSM | 3 | $72.45 |
| Biogen, Inc. BIIB | 2 | $48.96 |
| UCB, Inc. UCB.BR | 1 | $28.36 |
| SK Life Science, Inc. | 1 | $28.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.